StandardAero and Cognition Therapeutics Report Earnings

StandardAero reported non-GAAP EPS of $0.40, beating estimates, with revenue of $1.6B, also exceeding expectations. Cognition Therapeutics reported GAAP EPS of -$0.04, beating estimates by $0.02.